Delphi Automotive, Pieris Pharmaceuticals, Array Biopharma Stocks Moving Today

Three stocks making big moves on the charts today are Delphi Automotive, Pieris Pharmaceuticals, and Array Biopharma

May 3, 2017 at 2:10 PM
facebook twitter linkedin

Apple's earnings report is still holding back the Dow this afternoon. Among specific stocks on the move are car tech specialist Delphi Automotive PLC (NYSE:DLPH), as well as biotech stocks Pieris Pharmaceuticals Inc (NASDAQ:PIRS) and Array Biopharma Inc (NASDAQ:ARRY). Here's a quick look at what's moving shares of DLPH, PIRS, and ARRY.

Delphi Automotive Hits New High on Earnings, Spin-Off News

DLPH stock is the top percentage gainer on the S&P 500 Index (SPX), up 9.5% today at $85.94, and earlier touching an annual high of $88.35, thanks to an earnings beat. The company also said it plans to spin off its powertrain business. With today's move, Delphi Automotive PLC is up 27.6% in 2017, and analysts are certainly bullish. At the moment, 13 of the 16 covering brokerage firms say to buy DLPH stock

AstraZeneca Deal Puts Pieris Near the Top of the Nasdaq

PIRS stock is soaring today, due to news of a $57.5 million deal with AstraZeneca plc (ADR) (NYSE:AZN) to develop drugs for respiratory issues. The stock is one of the top gainers on the Nasdaq at last check, up 54.6% at $3.71 -- bringing its year-to-date advance to 164%. Plenty of short sellers are getting burned, too. Short interest on Pieris Pharmaceuticals Inc jumped by 61% over the past two reporting periods. 

Analyst Upgrade Helps Array Biopharma Shares Rebound

After taking a 16% hit yesterday, ARRY stock is bouncing back, thanks to an upgrade to "overweight" at J.P. Morgan Securities. The shares are now trading back atop their rising 200-day moving average, adding 6.6% today at $7.85. This is likely good news for options traders, who have shown bullish tendencies. For instance, Array Biopharma Inc has a 50-day call/put volume ratio of 40.39 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) , which ranks in the 91st annual percentile. 


Stop leaving money on the table with the same old broken options trading approach...

There is no options strategy that more perfectly capitalizes during earnings season better than this simple call and put buying strategy. Perfect for aggressive traders looking to recover their suffering portfolios so far in 2022. With the simplest possible options strategy, Schaeffer's team with 100+ years of options trading excellence, target 200% gains on every single trade. So many trades are being beaten down by the market, but don't be one of them! Don't waste another second... join us right now before the next trade is released! 

Best stocks for October and worst stocks for October


Special Offers from Schaeffer's Trading Partners